Key Takeaway: Standard glutathione supplements often have poor bioavailability
There are a handful of reasons: Obesity : 1 in 8 is obese worldwide, doubled since 1990 Usage : increasing into apnea, kidney and heart health, in testing for cancer & addiction Ease : pills will bring down costs and increase usage Innovation : new drugs bring greater weight loss, fewer side effects and unique action Cost : pills, generics, subsidies, insurance and increased competitors all drive price down Q: Is GLP-1 a trend that is likely to stay or is the bubble about to burst
As of 2023, there are active phase-1 clinical trials that investigate the potential effectiveness of this peptide for weight loss
Menstrual blood-derived stromal stem cells from women with and without endometriosis reveal different phenotypic and functional characteristics [J]
[box type=note]The study authors noted that the daily dose of 1.5 g/d of GPLC taken for 28 days resulted in similar improvements anaerobic sprint performance to taking a single dose of 4.5 g prior to exercise
Here is what Hers cannot promise